Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.

Telogen Effluvium causes increased hair shedding and can be challenging to diagnose and treat.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Stress can cause temporary hair loss, which usually gets better after the stress is gone.

Understanding and addressing the causes of telogen effluvium is crucial for effective treatment.

Post-COVID-19 hair loss is likely due to stress and inflammation.

Chronic telogen effluvium is a common hair loss condition with specific characteristics and treatment options.

Effective anesthesia strategies can help minimize hair loss in patients with telogen effluvium during surgery.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Babies born after 38 weeks to mothers under 36 years old and not delivered by C-section have a higher risk of neonatal occipital alopecia.

"Telogen defluxion" is a better term for hair loss than "telogen effluvium."

No effective treatment for hair loss after childbirth was found, but it usually gets better on its own and some cosmetic methods might help.

Hair loss called telogen effluvium can be better understood by looking at a patient's medical history.

The condition is harmless, doesn't worsen, and needs no invasive treatment.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

A woman's significant hair loss was linked to rapid weight loss and hormone injections.

Pigtail hair is a sign of new hair growth and should be recognized in hair loss conditions like acute telogen effluvium.

Most Iraqi women with telogen effluvium did not have a clear cause for their hair loss, and few had significant thinning.

A 6-year-old girl experienced temporary hair loss after mild COVID-19, which improved naturally in 8 months.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

Most Iraqi women with telogen effluvium had no clear cause for their hair loss, and few had significant thinning.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

COVID-19 has increased hair loss, but many patients see regrowth within months.

No specific treatment for postpartum hair loss is proven effective.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

COVID-19 infection may cause hair loss.

A patient's hair loss after a browlift surgery improved on its own over 8 months.

Chronic telogen effluvium is a condition that causes ongoing hair shedding.